Massachusetts Financial Services’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
74,619
+28,241
+61% +$328K ﹤0.01% 841
2025
Q4
$446K Sell
46,378
-1,533
-3% -$14.7K ﹤0.01% 878
2025
Q3
$450K Buy
47,911
+3,150
+7% +$30.1K ﹤0.01% 834
2025
Q2
$474K Buy
44,761
+554
+1% +$6.99K ﹤0.01% 851
2025
Q1
$664K Sell
44,207
-1,006
-2% -$16.7K ﹤0.01% 832
2024
Q4
$744K Sell
45,213
-1,351
-3% -$26.6K ﹤0.01% 827
2024
Q3
$1.15M Sell
46,564
-1,127
-2% -$29.2K ﹤0.01% 788
2024
Q2
$1.21M Buy
47,691
+1,601
+3% +$41.5K ﹤0.01% 787
2024
Q1
$1.17M Buy
+46,090
New +$1.12M ﹤0.01% 776
2014
Q2
Sell
-15,510
Closed -$637K 889
2014
Q1
$637K Sell
15,510
-14,530
-48% -$540K ﹤0.01% 808
2013
Q4
$1.15M Buy
30,040
+12,340
+70% +$381K ﹤0.01% 712
2013
Q3
$423K Sell
17,700
-650
-4% -$14.6K ﹤0.01% 797
2013
Q2
$312K Buy
+18,350
New +$265K ﹤0.01% 783

Other funds holding ANIK